Trade Olema Pharmaceuticals, Inc. - OLMA CFD

Trading Conditions

• Type: CFD
• Spread: 0.11
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 14.91
• Open: 14.79
• 1-Year Change: 263.39%
• Day's Range: 14.05 - 14.79

What is Olema Pharmaceuticals, Inc. (OLMA)?

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of therapies targeting cancer and other diseases. The company focuses on advancing novel drug candidates that modulate specific biological pathways implicated in disease progression. Olema Pharmaceuticals employs research and development strategies aimed at addressing unmet medical needs through innovative treatment approaches. The company collaborates with academic institutions and industry partners to support its clinical programs. Its operations include preclinical research, clinical trials, and regulatory activities necessary for drug development.

Olema Pharmaceuticals, Inc. Stock Price Today: Live Overview

The price today is shaped by active market trading for Olema Pharmaceuticals, Inc., currently at $14.16. It has fluctuated between $13.99 and $14.93 today, with a daily change percentage of -5.5182%.

FAQ: Olema Pharmaceuticals, Inc. (OLMA)

What is the current price of OLMA stock?

The latest price is $14.16.

Does OLMA pay dividends?

Olema Pharmaceuticals, Inc. does not pay dividends.

Does OLMA have a formal corporate presence or regional headquarters in the UAE?

Olema Pharmaceuticals, Inc. operates in the UAE through partnerships without an official regional office.

What is OLMA best known for?

Olema Pharmaceuticals, Inc. is most famous for developing treatments for breast cancer.

What assets are typically shown together with OLMA?

Commonly shown alongside OLMA: Corbus Pharmaceuticals, TriplePoint Venture Growth BDC Corp, Western Alliance Bancorp